Cancer Research Breakthroughs Archives - NFCR

Cancer Research Breakthroughs

At Its Root

Chaos can be surprisingly orderly. While cancer is characterized by uncontrolled cell growth, that growth is, nevertheless, the result of a very particular cascade of events, from carcinogen exposure to genetic mutations. Interfere with that cascade, and cancer can be ground to a halt, or even killed off. The efforts…...

Read more

Ancient Wisdom, Modern Cure

“Chinese traditional medicine” (TCM) is a cultural catch-all term for a series of practices including herbal medicine, diet, acupuncture, massage and exercise (like tai chi) whose combined history stretches back over four thousand years. Western science acknowledges the benefits of some forms of TCM — acupuncture and Chinese massage techniques,…...

Read more

Shining a Light (on Tumors)

There is a necessary truth about a surgical procedure: It’s not “neat.” There will be blood. There will be stitches. There will be some pain, discomfort and a recovery period. In the case of cancer, there might also be a second surgery. “When surgeons go in to remove a cancer,…...

Read more

An Analytical Tool Like Few Others

When he passed away in April 2004, Dr. Csaba Horváth had more than a few laurels upon which he could eternally rest. Though most famously, Horváth was the first scientist to design, construct and show molecular separations using high-performance liquid chromatography (HPLC). The analytical technology has since served as foundation…...

Read more

When The Internet First Took On Cancer

It was 2001 and Graham Richards, Ph.D., a scientist funded from 1982 to 2007 by the National Foundation for Cancer Research, was faced with a challenge: How to harness the power of a supercomputer for virtual cancer drug models when you have neither the budget nor the space required? The…...

Read more

Crizotinib Plus Radiation May Reduce NF2-Related Hearing Loss

A study co-authored by National Foundation for Cancer Research Fellow Dr. Rakesh Jain hints that adding the cancer drug crizotinib to the radiation therapy for tumors associated with neurofibromatosis 2 (NF2) may lessen the hearing loss that often precipitates from radiotherapy. Although not a cancer, NF2 is characterized by benign…...

Read more

Targeted Lung Cancer Therapy

A Match Made Possible A discovery by a team led by Massachusetts General Hospital’s Daniel Haber, M.D., Ph.D., a physician-scientist supported by the National Foundation for Cancer Research since 2003, now represents a source of hope for many patients with metastatic lung cancer. He and his colleagues correctly linked very…...

Read more

Liquid Biopsy Advances: Capturing Metastatic Cancer Cells

A novel instrument for detecting cancer cells in the blood could lead to individualized cancer treatments for patients suffering metastasis. Developed by a Massachusetts General Hospital team led by Daniel Haber, M.D., Ph.D., a renowned cancer scientists supported by the National Foundation for Cancer Research since 2003, the business card-sized…...

Read more

Dr. Doug Lowy on the Future of Cancer Research

Dr. Lowy, in collaboration with Dr. John Schiller, has been awarded the 2018 Szent-Györgyi prize for Progress in Cancer Research for their development of a preventive vaccine for human papilloma virus, which is the leading cause of cervical cancer cases. See why Dr. Lowy thinks that the problems with cancer…...

Read more

Artemisinin Therapies: Connecting the Dots

You wouldn’t think it, but the science cannot be denied: One of the newest and most promising drug candidates for cancer was actually developed all the way back in 1972. For malaria. “There were some hints in the literature, but we were totally ignorant,” admits Curt Civin, M.D., whose work…...

Read more